New Key Statistics Module, Z-Score and F-Score
DHA:ORIONPHARM Key Ratios
Market Cap BDT M | 8,119.80 |
Enterprise Value BDT M | 30,213.84 |
P/E(ttm) | 18.18 |
PE Ratio without NRI | 18.19 |
Forward PE Ratio | -- |
Price/Book | 0.38 |
Price/Sales | 0.73 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | 0.51 |
Revenue (TTM) BDT M | 11,496.00 |
EPS (TTM) BDT | 1.95 |
Beneish M-Score | -2.98 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -4.00 |
y-y EBITDA Growth Rate % | -31.80 |
EV-to-EBIT | 41.80 |
EV-to-EBITDA | 24.16 |
PEG | -- |
Shares Outstanding M | 234.00 |
Net Margin (%) | 3.96 |
Operating Margin % | 5.80 |
Pre-tax Margin (%) | 4.82 |
Quick Ratio | 1.67 |
Current Ratio | 1.86 |
ROA % (ttm) | 0.85 |
ROE % (ttm) | 2.17 |
ROIC % (ttm) | 1.18 |
Dividend Yield % | 2.88 |
Altman Z-Score | 0.82 |
DHA:ORIONPHARM Number of Guru Trades
DHA:ORIONPHARM Volume of Guru Trades
Gurus Latest Trades with DHA:ORIONPHARM
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
DHA:ORIONPHARM is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data